Last close · 16 Oct 2026
Rs 41.37 -0.22%
Financials
IBL HealthCare Limited (IBLHL) financials
16 years of annual results (FY2011 – FY2026), 52 quarters.
IBL HealthCare Limited (IBLHL) reported revenue of Rs 4.6 bn for FY2026 (Jul 2025 – Jun 2026), up 6.6% from FY2025.
Profit attributable to shareholders was Rs 220.4 mn (EPS Rs 2.24), up 5.8%, a net margin of 4.8%.
The balance sheet showed net cash of Rs 700.6 mn.
Return on equity was 9.1%.
Over the last five years revenue grew at a compound 8.9% a year.
At Rs 41.37 (close on 16 Oct 2026) the shares trade at 18.5× earnings (FY2026).
Fundamentals
IBLHL at a glance
Revenue · FY2026
Rs 4.6 bn
▲ 6.6% year on year
Profit attributable to shareholders · FY2026
Rs 220.4 mn
▲ 5.8% year on year
EPS – basic (Rs) · FY2026
Rs 2.24
▲ 6.0% year on year
Net margin · FY2026
4.8%
0.0 pts year on year
Debt to equity · FY2026
1.0%
-5.8 pts year on year
Financial statements
Income statement
Revenue, costs, profit and earnings per share.
- Revenue · FY2026
- Rs 4.6 bn
- Profit attributable · FY2026
- Rs 220.4 mn
Balance sheet
Assets, liabilities, debt and shareholders' equity.
- Total assets · FY2026
- Rs 4.0 bn
- Equity · FY2026
- Rs 2.5 bn
Financial highlights
IBLHL financial results
| Rs mn | FY2026 Jul 2025 – Jun 2026 | FY2025 Jul 2024 – Jun 2025 | FY2024 Jul 2023 – Jun 2024 | FY2023 * Jul 2022 – Jun 2023 | FY2022 Jul 2021 – Jun 2022 | FY2021 Jul 2020 – Jun 2021 | FY2020 Jul 2019 – Jun 2020 | FY2019 Jul 2018 – Jun 2019 | FY2018 Jul 2017 – Jun 2018 | FY2017 Jul 2016 – Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,607.1 | 4,322.5 | 3,603.4 | 4,027.9 | 3,651.1 | 3,003.9 | 2,664.6 | 1,585.0 | 1,358.3 | 1,189.8 |
| Gross profit | 1,644.8 | 1,447.0 | 951.8 | 1,340.4 | 1,256.2 | 1,022.5 | 811.3 | 443.9 | 428.5 | 397.9 |
| Operating profit | — | 444.6 | 143.3 | 631.7 | 582.6 | 438.8 | 352.6 | 204.1 | 213.7 | 254.0 |
| Profit after tax | 220.4 | 208.4 | 7.6 | 309.0 | 302.9 | 300.5 | 220.0 | 121.4 | 149.3 | 198.4 |
| Profit attributable to shareholders | 220.4 | 208.4 | 7.6 | 309.0 | 302.9 | 300.5 | 220.0 | 121.4 | 149.3 | 198.4 |
| EPS – basic (Rs) Rs | 2.24 | 2.11 | 0.08 | 3.14 | 2.56 | 3.05 | 2.23 | 1.23 | 1.52 | 2.01 |
| Dividend per share (Rs) Rs | — | 0.00 | 0.00 | 0.00 | 0.72 | 0.55 | 1.10 | 0.55 | 0.55 | 0.50 |
| Total assets | 4,034.2 | 4,010.0 | 3,326.8 | 3,553.7 | 2,929.5 | 2,446.7 | 2,252.0 | 1,888.8 | 1,399.9 | 1,317.1 |
| Total equity | 2,543.5 | 2,323.1 | 2,114.7 | 2,107.1 | 1,863.1 | 1,614.3 | 1,422.0 | 1,256.0 | 1,188.8 | 1,088.6 |
| Total debt | 26.6 | 159.0 | 22.4 | 297.6 | 267.2 | 258.7 | 178.7 | 167.5 | 0.0 | — |
| Net cash from operating activities | 659.2 | (259.7) | 568.0 | 27.2 | 56.9 | 70.0 | 40.4 | 12.4 | 63.2 | 144.5 |
| Capital expenditure | (5.9) | (19.1) | (1.6) | (3.1) | (1.3) | (5.8) | (4.7) | (13.1) | (6.2) | (49.5) |
| Free cash flow (operating cash flow − capex) | 653.3 | (278.8) | 566.4 | 24.0 | 55.6 | 64.2 | 35.8 | (0.6) | 57.0 | 95.0 |
| Rs mn | TTM to Jun 2026 | Q4 FY2026 Apr – Jun 2026 | Q3 FY2026 Jan – Mar 2026 | Q2 FY2026 Oct – Dec 2025 | Q1 FY2026 Jul – Sep 2025 | Q4 FY2025 Apr – Jun 2025 | Q3 FY2025 Jan – Mar 2025 | Q2 FY2025 Oct – Dec 2024 | Q1 FY2025 Jul – Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,607.1 | 1,302.3 | 1,212.7 | 971.1 | 1,120.9 | 1,177.8 | 948.0 | 1,117.7 | 1,079.0 |
| Gross profit | 1,644.8 | 400.1 | 442.8 | 401.8 | 400.1 | 458.9 | 313.3 | 334.9 | 339.9 |
| Operating profit | — | — | 144.5 | 87.0 | 132.3 | 136.0 | 80.2 | 102.2 | 118.9 |
| Profit after tax | 220.4 | 52.9 | 61.9 | 35.9 | 69.7 | 72.9 | 35.4 | 40.2 | 59.9 |
| Profit attributable to shareholders | 220.4 | 52.9 | 61.9 | 35.9 | 69.7 | 72.9 | 35.4 | 40.2 | 59.9 |
| EPS – basic (Rs) Rs | — | — | 0.63 | 0.36 | 0.70 | 0.74 | 0.36 | 0.41 | 0.61 |
| Dividend per share (Rs) Rs | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total assets | 4,034.2 | 4,034.2 | 4,343.1 | 4,340.4 | 4,188.9 | 4,010.0 | 3,657.4 | 3,493.3 | 3,655.5 |
| Total equity | 2,543.5 | 2,543.5 | 2,490.5 | 2,428.6 | 2,392.7 | 2,323.1 | 2,250.1 | 2,214.7 | 2,174.5 |
| Total debt | 26.6 | 26.6 | 456.5 | 452.5 | 456.8 | 159.0 | 391.1 | 390.7 | 420.0 |
| Net cash from operating activities | 659.2 | 1,049.0 | 19.7 | 69.7 | (479.3) | 414.9 | (5.9) | 10.7 | (679.4) |
| Capital expenditure | (5.9) | (1.1) | (0.9) | (1.2) | (2.7) | (0.8) | (17.5) | (0.1) | (0.7) |
| Free cash flow (operating cash flow − capex) | 653.3 | 1,047.9 | 18.8 | 68.6 | (482.0) | 414.1 | (23.4) | 10.6 | (680.1) |
Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 16 Oct 2026.